(Q37315949)

19 August 2017

1 reference

title

Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs (English)

1 reference

19 August 2017

0 references

cervix uterine cancer

1 reference

4

Shannon Stokley

1 reference

19 August 2017

7

Vicki Benard

1 reference

19 August 2017

3

Donatus U Ekwueme

1 reference

19 August 2017

Kris Khan

1

1 reference

19 August 2017

C Robinette Curtis

2

1 reference

19 August 2017

Chastity Walker

5

1 reference

19 August 2017

Katherine Roland

6

1 reference

19 August 2017

Mona Saraiya

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

113

1 reference

19 August 2017

10 Suppl

1 reference

19 August 2017

3004-3012

1 reference

Cervical cancer incidence in the United States by area of residence, 1998 2001.

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

Evaluating human papillomavirus vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

Cost-effectiveness of a potential vaccine for human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30s.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Trends in emergency Medicaid expenditures for recent and undocumented immigrants.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Financing immunization of adults in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Vaccines for Children program, United States, 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

The role of measles elimination in development of a national immunization program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

The potential of human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Emerging Technologies and Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Delivering on the promise: HPV vaccines and cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Prevalence of HPV infection among females in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Cost-effectiveness analyses of human papillomavirus vaccination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23765

7 January 2021

Identifiers

DOI

10.1002/CNCR.23765

1 reference

19 August 2017

1 reference